Document is current
Any future updates will be listed below
-
Authors
Holt, Jeffrey R. http://orcid.org/0000-0002-7182-8011
Tobin, Mélanie
Elferich, Johannes
Gouaux, Eric
Ballesteros, Angela
Yan, Zhiqiang
Ahmed, Zubair M.
Nicolson, Teresa
-
Funding
Funding for this research was provided by:
National Institute on Deafness and Other Communication Disorders (R01-DC013521, R01-DC013572, R01-DC013531)
Agence Nationale de la Recherche (ANR-11-BSV5 0011, ANR-16-CE13-0015)
Labex (ANR-10-LABX-0038)
Howard Hughes Medical Institute
National Institute of Neurological Disorders and Stroke (NS002945)
- License Information
-
More Information
Article History
Received: 26 May 2021
Accepted: 16 July 2021
First Online: 6 October 2021
Declarations
:
: J.R.H. holds patents on TMC1 gene therapy and is an advisor to several biotech firms focused on inner-ear therapies. The authors report no other conflicts.
